| Primary |
| Drug Use For Unknown Indication |
50.0% |
| Product Used For Unknown Indication |
24.1% |
| Hyperlipidaemia |
5.4% |
| Hypertension |
3.2% |
| Diabetes Mellitus |
3.0% |
| Dyslipidaemia |
1.4% |
| Metabolic Disorder |
1.2% |
| Antitussive Therapy |
1.1% |
| Chemotherapy |
1.1% |
| Diuretic Therapy |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Blood Triglycerides Increased |
0.9% |
| Eczema |
0.9% |
| Gout |
0.9% |
| Hypertriglyceridaemia |
0.9% |
| Blood Cholesterol |
0.7% |
| Essential Hypertension |
0.7% |
| Myocardial Ischaemia |
0.7% |
| Angina Pectoris |
0.6% |
|
| Liver Disorder |
14.4% |
| Renal Failure |
8.7% |
| Renal Impairment |
8.7% |
| Pyrexia |
6.7% |
| High Density Lipoprotein Decreased |
5.8% |
| Liver Function Test Abnormal |
5.8% |
| Pain In Extremity |
4.8% |
| Renal Failure Acute |
4.8% |
| Rhabdomyolysis |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Choking |
3.8% |
| Interstitial Lung Disease |
3.8% |
| Drug Interaction |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Insulin Resistance |
2.9% |
| Jaundice |
2.9% |
| Muscle Disorder |
2.9% |
| Myocardial Infarction |
2.9% |
| Rash |
2.9% |
| Sleep Disorder |
2.9% |
|
| Secondary |
| Adult T-cell Lymphoma/leukaemia |
22.2% |
| Product Used For Unknown Indication |
14.4% |
| Drug Use For Unknown Indication |
13.4% |
| Hyperlipidaemia |
7.5% |
| Constipation |
4.5% |
| Prophylaxis |
4.5% |
| Hypertension |
4.4% |
| Antifungal Prophylaxis |
3.8% |
| Chemotherapy |
3.1% |
| Diabetes Mellitus |
3.0% |
| Pneumonia |
3.0% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Stomatitis |
2.2% |
| Essential Hypertension |
1.9% |
| Dyslipidaemia |
1.8% |
| Proctitis |
1.8% |
| Pain |
1.7% |
| Hyperuricaemia |
1.4% |
| Pruritus |
1.4% |
| Hypercholesterolaemia |
1.3% |
|
| Interstitial Lung Disease |
13.7% |
| Pneumonia |
12.3% |
| Liver Function Test Abnormal |
6.8% |
| Renal Impairment |
6.8% |
| Rhabdomyolysis |
6.8% |
| Renal Failure Acute |
5.5% |
| Urticaria |
5.5% |
| Hepatic Function Abnormal |
4.1% |
| Intentional Overdose |
4.1% |
| Liver Disorder |
4.1% |
| Visual Field Defect |
4.1% |
| Weight Decreased |
4.1% |
| Blood Glucose Increased |
2.7% |
| Cholestasis |
2.7% |
| Gamma-glutamyltransferase Increased |
2.7% |
| Gastric Cancer |
2.7% |
| Hepatitis Acute |
2.7% |
| Insulin Resistance |
2.7% |
| Malaise |
2.7% |
| Myalgia |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.9% |
| Hypertension |
14.7% |
| Drug Use For Unknown Indication |
12.4% |
| Diabetes Mellitus |
7.2% |
| Hyperlipidaemia |
6.1% |
| Type 2 Diabetes Mellitus |
4.8% |
| Rheumatoid Arthritis |
4.1% |
| Pain |
4.1% |
| Prophylaxis |
4.0% |
| Hiv Infection |
3.8% |
| Depression |
2.8% |
| Blood Cholesterol Increased |
2.6% |
| Gastritis |
2.6% |
| Osteoporosis |
2.4% |
| Psoriasis |
2.2% |
| Insomnia |
2.1% |
| Constipation |
2.0% |
| Atrial Fibrillation |
1.8% |
| Crohn's Disease |
1.8% |
| Dyslipidaemia |
1.8% |
|
| Liver Disorder |
10.8% |
| Vomiting |
9.0% |
| Renal Failure Acute |
7.2% |
| Pulmonary Oedema |
6.6% |
| Weight Decreased |
6.6% |
| Interstitial Lung Disease |
6.0% |
| Cerebral Infarction |
5.4% |
| Cardiac Failure |
4.2% |
| Death |
4.2% |
| Hypoglycaemia |
4.2% |
| Sepsis |
4.2% |
| Weight Increased |
4.2% |
| Anaphylactic Shock |
3.6% |
| Angina Pectoris |
3.6% |
| Hepatic Function Abnormal |
3.6% |
| Rash |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Bladder Cancer |
3.0% |
| Blood Glucose Increased |
3.0% |
| Gamma-glutamyltransferase Increased |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
72.2% |
| Dyslipidaemia |
11.1% |
| Myocardial Ischaemia |
11.1% |
| Blood Pressure |
5.6% |
|
| Hypotension |
50.0% |
| Sleep Disorder |
50.0% |
|
